238 results on '"Doherty, T. Mark"'
Search Results
2. Healthy ageing: Herpes zoster infection and the role of zoster vaccination
3. Capturing the Value of Vaccination within Health Technology Assessment and Health Economics—Practical Considerations for Expanding Valuation by Including Key Concepts.
4. Evaluation of Mycobacterium tuberculosis-Specific Antibody Responses in Populations with Different Levels of Exposure from Tanzania, Ethiopia, Brazil, and Denmark
5. Combining host-derived biomarkers with patient characteristics improves signature performance in predicting tuberculosis treatment outcomes
6. Identification of subclinical tuberculosis in household contacts using exposure scores and contact investigations
7. Long-Lived Immune Response to Early Secretory Antigenic Target 6 in Individuals Who Had Recovered from Tuberculosis
8. Vaccination programs for older adults in an era of demographic change
9. Ex-vivo characterization of regulatory T cells in pulmonary tuberculosis patients, latently infected persons, and healthy endemic controls
10. Fighting against a protean enemy: immunosenescence, vaccines, and healthy aging
11. Review of the unmet medical need for vaccination in adults with immunocompromising conditions: An Indian perspective.
12. High Heritability of Antimycobacterial Immunity in an Area of Hyperendemicity for Tuberculosis Disease
13. Maintaining a 'fit' immune system: the role of vaccines.
14. Lifting non-pharmaceutical interventions following the COVID-19 pandemic – the quiet before the storm?
15. Comparative Analysis of Different Vaccine Constructs Expressing Defined Antigens from Mycobacterium tuberculosis
16. Tuberculin Skin Test and In Vitro Assays Provide Complementary Measures of Antimycobacterial Immunity in Children and Adolescents
17. Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice
18. Biomarkers for tuberculosis disease activity, cure, and relapse
19. Resistance to Murine Acquired Immunodeficiency Syndrome (MAIDS)
20. Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations
21. Evaluation of Mycobacterium tuberculosis - specific antibody responses in populations with different levels of exposure from Tanzania, Ethiopia, Brazil, and Denmark
22. The prognosis of latent tuberculosis: can disease be predicted?
23. The success and failure of BCG — implications for a novel tuberculosis vaccine
24. Progress and hindrances in tuberculosis vaccine development
25. Precision Medicine and Vaccination of Older Adults: From Reactive to Proactive (A Mini-Review).
26. Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6
27. Real world TB vaccines: clinical trials in TB-endemic regions
28. Unveiling the contributions of immunization for progressing towards Universal Health Coverage.
29. The potential of recombinant antigens ESAT-6, MPT63 and mig for specific discrimination of Mycobacterium tuberculosis and M. avium infection
30. Increased expression of mRNA encoding interleukin (IL)-4 and its splice variant IL-4δ2 in cells from contacts of Mycobacterium tuberculosis, in the absence of in vitro stimulation
31. New vaccines against tuberculosis
32. CORRELATION OF DISEASE STATUS AND T-CELL RECOGNITION OF MYCOBACTERIUM TUBERCULOSIS-SPECIFIC ANTIGENS.
33. Potential of novel Mycobacterium tuberculosis infection phase-dependent antigens in the diagnosis of TB disease in a high burden setting
34. A TRANSGENIC MOUSE MODEL FOR HIV PROVIRUS ACTIVATION FROM MONONUCLEAR PHAGOCYTES.
35. Interferon (IFN) Consensus Sequence-binding Protein, a Transcription Factor of the IFN Regulatory Factor Family, Regulates Immune Responses In Vivo through Control of Interleukin 12 Expression
36. First in humans: A new molecularly defined vaccine shows excellent safety and strong induction of long-lived
37. Effect of vaccination on the use of antimicrobial agents: a systematic literature review.
38. Adult vaccination as part of a healthy lifestyle: moving from medical intervention to health promotion.
39. Incidence of tuberculosis and the influence of surveillance strategy on tuberculosis case-finding and all-cause mortality: a cluster randomised trial in Indian neonates vaccinated with BCG.
40. Effect of Non-tuberculous Mycobacteria on Host Biomarkers Potentially Relevant for Tuberculosis Management
41. Response letter Re: The burden of seasonal influenza: improving vaccination coverage to mitigate morbidity and its impact on healthcare systems.
42. Combination of cytokine responses indicative of latent TB and active TB in Malawian adults
43. Maternal immunization: where are we now and how to move forward?
44. Challenges in adult vaccination.
45. A phase I, open-label trial on the safety and immunogenicity of the adjuvanted tuberculosis subunit vaccine H1/IC31® in people living in a TB-endemic area.
46. A T cell-inducing influenza vaccine for the elderly: safety and immunogenicity of MVA-NP+M1 in adults aged over 50 years
47. Modulation of Cell Death by M. tuberculosis as a Strategy for Pathogen Survival
48. Ex vivo cytokine mRNA levels correlate with changing clinical status of ethiopian TB patients and their contacts over time
49. Incidence of tuberculosis among school-going adolescents in South India.
50. Added Value of IP-10 as a Read-Out of Mycobacterium tuberculosis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.